Table 5.

BAT in immediate NMBA hypersensitivity

Stimulus	Ref. test	Activation marker	Sensitivity (%)	Specificity (%)	N	Ref.
Various NMBA	H	CD63 CD45	64 43	81 96	26	[123]
Various NMBA	H + ST	CD63	54	100	56	[12]
Various NMBA	H	CD63 CD203c	79 36	100 100	31	[124]
Various NMBA	H + ST	CD63	36–86a	93	92	[125]
Rocuronium	H + ST	CD63	92b	100	22	[71]
Various NMBA	H + ST + IgE	CD63	60	100	49	[126]
Rocuronium	H	CD63	80	96	104	[68]
Various NMBA	H + ST	CD63	68	100	56	[127]
Atracurium	H + ST	CD63	71c	100	75	[72]

BAT basophil activation test, H history, IgE immunoglobulin E, N number of patients and control individuals, NMBA neuromuscular blocking agent, Ref. reference, ST skin test

^aIncreasing sensitivity when only the reactions that occurred during the 3 years were taken into account

^bTaking into account the non-responders, sensitivity is 76%

^cTaking into account the non-responders, sensitivity is 63%